id: NEW:sbirt_implementation_inpatient_to_30_day_hospital_readmission_rate
name: Inpatient SBIRT Implementation for Alcohol Use Disorder â†’ 30-Day Hospital Readmission Rate (90-day)
from_node:
  node_id: NEW:sbirt_implementation_inpatient
  node_name: Inpatient SBIRT Implementation for Alcohol Use Disorder
to_node:
  node_id: 30_day_hospital_readmission_rate
  node_name: 30-Day Hospital Readmission Rate (90-day)
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Inpatient SBIRT identifies alcohol use disorder and initiates treatment engagement during acute
  hospitalization'
- 'Step 2: Brief intervention addresses ambivalence about alcohol use and enhances motivation for change'
- 'Step 3: Referral to treatment establishes connection to outpatient addiction services for sustained
  care'
- 'Step 4: Continued engagement with treatment services supports ongoing abstinence or reduced drinking'
- 'Step 5: Sustained reduction in alcohol consumption prevents progression of liver disease and need for
  rehospitalization'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Dennis Wang and M. Puglia 2023. "Inpatient Screening, Brief Intervention, and Referral
    to Treatment for Alcohol Use Disorder in Patients Admitted with Alcohol-associated Liver Disease Is
    Not Universally Implemented in Practice, But Can Reduce Readmissions for Alcohol-associated Hepatitis."
    https://doi.org/10.1093/jcag/gwad048
  supporting_citations:
  - Additional citations require full-text access - abstract does not provide references to prior SBIRT
    studies
  - Additional citations require full-text access - abstract does not reference foundational alcohol-liver
    disease literature
  - Additional citations require full-text access - abstract does not cite multidisciplinary care guidelines
  doi: 10.1093/jcag/gwad048
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Inpatient SBIRT conducted during hospitalization for alcohol-associated hepatitis was associated
  with an 83% reduction in odds of 90-day readmission (OR 0.166, 95% CI 0.052-0.534, p=0.003). This sustained
  effect suggests SBIRT may facilitate lasting behavior change or treatment engagement.
quantitative_effects:
  effect_size:
    value: 0.166
    type: odds_ratio
    ci_lower: 0.052
    ci_upper: 0.534
  p_value: 0.003
  sample_size: 120
moderators:
- name: diagnosis_type
  direction: strengthens
  strength: strong
  description: SBIRT effect was significant for alcohol-associated hepatitis (AAH) but NOT for decompensated
    alcohol-related cirrhosis (DARLC), suggesting earlier disease stage or reversibility may moderate
    intervention effectiveness
structural_competency:
  equity_implications: The persistence of protective effects at 90 days demonstrates how healthcare system
    organization shapes long-term outcomes. Patients without SBIRT access face ongoing structural barriers
    to addiction treatment, perpetuating cycles of hospitalization. This represents a healthcare equity
    issue - receipt of evidence-based addiction care during hospitalization is determined by institutional
    protocols and provider practices rather than patient need.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.067740'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
